Tornack Julia, Kawano Yohei, Garbi Natalio, Hämmerling Günter J, Melchers Fritz, Tsuneto Motokazu
Senior Group Lymphocyte Development, Max Planck Institute for Infection Biology, Berlin, Germany.
Division of Molecular Immunology, German Cancer Research Center, Heidelberg, Germany.
Eur J Immunol. 2017 Sep;47(9):1477-1487. doi: 10.1002/eji.201646730. Epub 2017 Jul 26.
The pool of hematopoietic stem cells (HSCs) in the bone marrow is a mixture of resting, proliferating, and differentiating cells. Long-term repopulating HSCs (LT-HSC) are routinely enriched as Lin Sca1 c-Kit CD34 Flt3 CD150 CD48 cells. The Flt3 ligand (Flt3L) and its receptor Flt3 are important regulators of HSC maintenance, expansion and differentiation. Using Flt3L-eGFP reporter mice, we show that endogenous Flt3L-eGFP-reporter RNA expression correlates with eGFP-protein expression. This Flt3L-eGFP-reporter expression distinguishes two LT-HSC populations with differences in gene expressions and reconstituting potential. Thus, Flt3L-eGFP-reporter cells are identified as predominantly resting HSCs with long-term repopulating capacities. In contrast, Flt3L-eGFP-reporter cells are in majority proliferating HSCs with only short-term repopulating capacities. Flt3L-eGFP-reporter cells express hypoxia, autophagy-inducing, and the LT-HSC-associated genes HoxB5 and Fgd5, while Flt3L-eGFP-reporter HSCs upregulate genes involved in HSC differentiation. Flt3L-eGFP-reporter cells develop to Flt3L-eGFP-reporter cells in vitro, although Flt3L-eGFP-reporter cells remain Flt3L-eGFP-reporter . CD150 Flt3L-eGFP-reporter cells express either endothelial protein C receptor (EPCR) or CD41, while Flt3L-eGFP-reporter cells do express EPCR but not CD41. Thus, FACS-enrichment of Flt3/ Flt3L-eGFP-reporter negative, Lin CD150 CD48 EPCR CD41 HSCs allows a further 5-fold enrichment of functional LT-HSCs.
骨髓中的造血干细胞(HSC)库是静止、增殖和分化细胞的混合物。长期重建造血干细胞(LT-HSC)通常富集为Lin-Sca1+c-Kit+CD34-Flt3-CD150+CD48-细胞。Flt3配体(Flt3L)及其受体Flt3是HSC维持、扩增和分化的重要调节因子。利用Flt3L-eGFP报告基因小鼠,我们发现内源性Flt3L-eGFP报告基因RNA表达与eGFP蛋白表达相关。这种Flt3L-eGFP报告基因表达区分了两个LT-HSC群体,它们在基因表达和重建造血潜能上存在差异。因此,Flt3L-eGFP报告基因细胞被鉴定为主要是具有长期重建造血能力的静止造血干细胞。相比之下,Flt3L-eGFP报告基因细胞大多数是仅具有短期重建造血能力的增殖造血干细胞。Flt3L-eGFP报告基因细胞表达缺氧、自噬诱导相关基因以及与LT-HSC相关的基因HoxB5和Fgd5,而Flt3L-eGFP报告基因造血干细胞上调参与造血干细胞分化的基因。Flt3L-eGFP报告基因细胞在体外发育为Flt3L-eGFP报告基因细胞,尽管Flt3L-eGFP报告基因细胞仍然是Flt3L-eGFP报告基因细胞。CD150+Flt3L-eGFP报告基因细胞表达内皮蛋白C受体(EPCR)或CD41,而Flt3L-eGFP报告基因细胞表达EPCR但不表达CD41。因此,通过流式细胞术富集Flt3/Flt3L-eGFP报告基因阴性、Lin-CD150+CD48-EPCR+CD41-造血干细胞可使功能性LT-HSC进一步富集5倍。